QA: Aravive Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2021_Aravive_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001513818, Aravive Inc

  xvar xval
0 AssetsCurrent 61,689,000
1 IntangibleAssetsNetIncludingGoodwill 97,000
2 PropertyPlantAndEquipmentNet 526,000
3 remainder_Assets 5,398,000
4 LiabilitiesCurrent 9,461,000
5 LiabilitiesNoncurrent 6,431,000
6 remainder_Liabilities 3,763,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,714,422
9 ResearchAndDevelopmentExpense 19,996,635
10 remainder_Expenses 4,482
11 remainder_Revenues 5,343,775
12 remainder_NetIncome 1,349,752
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 67,710,000
1 Liabilities 19,655,000
2 Expenses 32,715,539
3 Revenues 5,343,775
4 StockholdersEquity 48,055,000
5 NetIncome -26,022,012
6 ComprehensiveNetIncome -26,022,012
7 BaseVar 63,387,033
8 EconomicCapitalRatiobeforeLimitedLiability 1.80
9 EconomicCapitalRatio 2.89

Edgar->Model Mapping

Feature Distribution

Change over Time